Decrease (-) Restore Default Increase (+)

Clinical Trials

Topic   Allergy (Pediatrics)
Title   A multicenter, Open-Label, Non-Randomized Study to Assess the Tolerability and Safety of a Single, Subcutaneous Administration of Ecallantide in Children and Adolescents with Hereditary Angioedema
Summary   The purpose of this clinical research study to test how well and how safe an investigational medication works in children and adolescent with HAE
Description   NYU Winthrop Hospital, Clinical Trials Center is conducting this clinical research study for children and adolescents, ages 2- 15 years old who have been diagnosed with Hereditary Angioedema (swelling of the skin, abdomen and/or face and throat which occur repeatedly).

Eligible participants will receive study-related medical examinations, research medication and laboratory tests at no cost to you, during your participation in this research study. Compensation may also be provided for time and travel.
IRB Number   NA
Inclusion/Notes   To be eligible for the study, you must;
  • be between 2 years old and 15 years old
  • have documented diagnosis with HAE
Principal Name   Mark Davis-Lorton, MD
Contact Name   NYU Winthrop Hospital - Clinical Trials Center
Fax   516-663-9587
Phone   516-663-9582